Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
OSI PHARMACEUTICALS INC (OSIP)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-10 | Dec-31-09 | Sep-30-09 | Jun-30-09 | Mar-31-09 | Dec-31-08 | Sep-30-08 | Jun-30-08 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 2.5% | 1.9% | 1.4% | 2.7% | 2.3% | 2.6% | 2.7% | 2.2% |
| Gross profit | 97.5% | 98.1% | 98.6% | 97.3% | 97.7% | 97.4% | 97.3% | 97.8% |
| Selling, general and administrative | 27.3% | 23.3% | 22.1% | 25.4% | 25.8% | 25.3% | 23.5% | 24.2% |
| Research and development | 39.4% | 32.8% | 34.6% | 37.5% | 37.8% | 42.0% | 35.0% | 31.8% |
| EBITDA | 23.8% | 45.2% | 43.8% | 36.4% | 36.0% | 33.0% | 40.9% | 45.0% |
| Depreciation | 3.0% | 2.3% | 3.0% | 2.0% | 2.0% | 3.0% | 2.1% | 3.2% |
| EBITA | 20.9% | 42.9% | 40.8% | 34.4% | 34.0% | 30.1% | 38.8% | 41.8% |
| Amortization of intangibles | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.6% | 0.7% | 0.7% |
| EBIT | 20.7% | 42.7% | 40.6% | 34.2% | 33.8% | 29.4% | 38.2% | 41.1% |
| Pre-tax income | 7.4% | 35.5% | 31.5% | 27.3% | 28.9% | 24.2% | 34.2% | 36.7% |
| Income taxes | 3.0% | 15.2% | 15.5% | 10.7% | 11.3% | -323.9% | 1.0% | 1.0% |
| Net income | 4.6% | 61.2% | 15.8% | 16.7% | 17.5% | 448.5% | 54.6% | 23.3% |
|